Tele: 561.316.3330
Breaking Medical Device News

Thursday, October 21, 2021


HomeEXECUTIVESJohn Toomey Appointed Vice President of Growth and Innovation of RMS Medical...

John Toomey Appointed Vice President of Growth and Innovation of RMS Medical Products

John Toomey has been appointed to the newly created position of Vice President of Growth and Innovation of RMS Medical Products. John Toomey brings to RMS over 30 years of medical device industry experience as an executive, patent officer, inventor, board member, and advisor.

Mr. Toomey will be responsible for research and development, product innovation, and business development, and integrating these capabilities across the enterprise. He will also play a key role in building a robust IP platform.

Mr. Toomey has held leadership roles at numerous medical device companies, including Pneuma Systems Corporation, Validose, Inc., Halkey-Roberts Corporation, Smith’s Medical, Inc., and CR Bard (acquired by Becton Dickinson). He also founded 2ME Mgmt Consultancy, LLC, which specialized in developing latent market opportunities and solving project, regulatory and IP challenges in the medical device space.

Mr. Toomey received his BS from Allegheny College, MBA from the Marshall School of Business at the University of Southern California, and JD from Thomas Jefferson School of Law.

Mr. Toomey holds 24 U.S. and foreign patents.

“Product innovation is a key driver of our previously announced strategic plan to become the preferred drug delivery partner for specific infusion therapies in select markets,” said Don Pettigrew, President and CEO of RMS Medical. “John has an impressive track record of developing and commercializing value-creating medical device solutions, and we are confident in his ability to help RMS pioneer new infusion products and applications. John is the latest in a series of strategic hires and appointments that we believe have positioned RMS Medical for continued growth and an elevated industry profile.”

“I am excited to join the team at RMS Medical at this important stage of development,” said Mr. Toomey. “The Company has a well-respected family of infusion therapy products, is addressing growing end markets, and is led by a seasoned and accomplished group of executives. I look forward to working with the team and building upon RMS Medical’s patient-focused platform.”


Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Contraline Closes $10.7 Million Series A Financing to Become a Clinical Stage Company

This infusion of capital will support the initiation of a first-in-human trial of ADAM™, the world’s first hydrogel implant designed to provide long-lasting, non-permanent contraception for men.

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Luciana Borio MD is a respected physician with vast experience in advancing major regulatory and policy agendas for the United States.

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

By using this website you agree to accept Medical Device News Magazine Privacy Policy